ZTS (STOCKS)
ZOETIS INC.
$79.900000
+0.330000 (+0.41%)
Prev close: $79.570000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kristin C. Peck
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $33,513.10M
- Employees
- 13,800
- P/E (TTM)
- 13.18
- P/B (TTM)
- 10.35
- Dividend Yield
- 258.89%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
10
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.53 | $1.63 | -0.1009 | -6.19% |
|
Dec 2025 (Q4)
|
$1.48 | $1.42 | +0.0641 | +4.53% |
|
Sep 2025 (Q3)
|
$1.70 | $1.64 | +0.0621 | +3.79% |
|
Jun 2025 (Q2)
|
$1.76 | $1.63 | +0.1266 | +7.75% |
Financial Statements
| Revenues | $9.51B |
| Benefits Costs and Expenses | $6.20B |
| Cost Of Revenue | $2.69B |
| Costs And Expenses | $6.20B |
| Gross Profit | $6.82B |
| Nonoperating Income/Loss | $38.00M |
| Operating Expenses | $3.52B |
| Selling, General, and Administrative Expenses | $2.40B |
| Other Operating Expenses | $1.11B |
| Operating Income/Loss | $3.31B |
| Income/Loss From Continuing Operations After Tax | $2.64B |
| Income/Loss From Continuing Operations Before Tax | $3.31B |
| Income Tax Expense/Benefit | $665.00M |
| Income Tax Expense/Benefit, Deferred | -$32.00M |
| Interest Expense, Operating | $230.00M |
| Net Income/Loss | $2.64B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.64B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.64B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.04 |
| Diluted Earnings Per Share | $6.03 |
| Basic Average Shares | 1,308,343,000 |
| Diluted Average Shares | 1,309,335,000 |
| Assets | $15.15B |
| Current Assets | $6.47B |
| Inventory | $2.55B |
| Other Current Assets | $3.92B |
| Noncurrent Assets | $8.68B |
| Fixed Assets | $3.72B |
| Intangible Assets | $959.00M |
| Other Non-current Assets | $4.00B |
| Liabilities | $11.92B |
| Current Liabilities | $2.05B |
| Accounts Payable | $507.00M |
| Wages | $239.00M |
| Other Current Liabilities | $1.31B |
| Noncurrent Liabilities | $9.87B |
| Equity | $3.23B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.23B |
| Liabilities And Equity | $15.15B |
| Net Cash Flow From Operating Activities | $2.79B |
| Net Cash Flow From Operating Activities, Continuing | $2.79B |
| Net Cash Flow From Investing Activities | -$632.00M |
| Net Cash Flow From Investing Activities, Continuing | -$632.00M |
| Net Cash Flow From Financing Activities | -$2.03B |
| Net Cash Flow From Financing Activities, Continuing | -$2.03B |
| Exchange Gains/Losses | $23.00M |
| Net Cash Flow | $148.00M |
| Net Cash Flow, Continuing | $125.00M |
| Comprehensive Income/Loss | $2.86B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.86B |
| Other Comprehensive Income/Loss | $215.00M |